INHIBIDORES DE LA PROTEASA NS3 DEL HCV

La presente invención se refiere a compuestos macrocíclicos de fórmula (I) que son útiles como inhibidores de la proteasa NS3 del virus de la hepatitis C (HCV), a su síntesis y a su uso para tratar o prevenir infecciones con HCV. The present invention relates to macrocyclic compounds of formula (I)...

Full description

Saved in:
Bibliographic Details
Main Authors ALESSIA PETROCCHI, CHARLES J. MCINTYRE, MICHAEL T. RUDD, MARCO POMPEI, NIGEL J. LIVERTON, MARIA EMILIAFRANCESCO, JOSEPH J. ROMANO, JOHN W. BUTCHER, JOHN A. MCCAULEY, KEVIN F. GILBERT, STEVEN HARPER, VINCENZO SUMMA, KATHARINE M. HOLLOWAY, MARCO FERRARA
Format Patent
LanguageSpanish
Published 05.03.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:La presente invención se refiere a compuestos macrocíclicos de fórmula (I) que son útiles como inhibidores de la proteasa NS3 del virus de la hepatitis C (HCV), a su síntesis y a su uso para tratar o prevenir infecciones con HCV. The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Bibliography:Application Number: NI20090000069